Protein Reagent Research Scientist 
Pharmaceutical Technology
SEPTEMBER 14, 2022
API peptides and proteins-based drugs have gained much attention in the past decade. Discover the top API protein and peptide companies in contract marketing. Technologies in the delivery of peptides and proteins. They are promising therapeutics for the treatment of a variety of metabolic and oncological disorders.
Drug Discovery World
MAY 25, 2023
The platform works with the SYNTAX Hi-Fidelity reagent kits for synthesising longer oligos. The modular, cloud native Torx platform enables chemistry teams to collaborate and share molecules, both internally and with contract research organisations (CROs) around the world.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
JANUARY 10, 2023
Our catalog of over 6,500+ primary antibodies, 1,200+ secondary antibodies, and 50+ ELISA kits includes reagents for multiplex IF, flow cytometry, and more in fields including immunology, oncology, and neuroscience. This pillar requires that two or more antibodies directed against different epitopes of a protein generate similar results.
Drug Discovery World
SEPTEMBER 29, 2022
For these reasons and others, many biotech and pharmaceutical companies – along with government research labs and academic institutions – rely on contract research organizations (CROs) for drug discovery services. Minimising reagent consumption and costs. Generating robust, reproducible data generating confidence in results.
Drug Discovery World
APRIL 3, 2023
DS: What motivated you and Dr David Bunka, CTO, to create Aptamer and did you imagine you would one day be operating on such a global scale? AT : We initially met at the University of Leeds, where David was a post-doctoral researcher studying aptamers, and I was completing my PhD. Optimer binders are engineered to overcome these problems.
Drug Discovery World
NOVEMBER 28, 2023
Scientists at the University of Bath have developed a way of joining up the head and tail of a protein, making it more stable and easier to get into cells. This new tool may help researchers develop new pharmaceuticals in a cleaner, greener, and less expensive way. It is therefore much simpler and cheaper.
Pharmaceutical Technology
APRIL 28, 2023
The company has been ranked in the Business Expansion and Research and Development categories in the Pharmaceutical Technology Excellence Rankings. Key among them has been the extension of Syngene’s research collaboration with leading biotech company Amgen Inc. until 2026. until 2026.
Expert insights. Personalized for you.
130 
Let's personalize your content